CRO aggressively entering into Korean markets.

Many (CRO) agencies arranging foreign clinical research works for domestic companies actively came into the market as its necessity is ever demanding now in Korea, viewing that the new drug R&D was highly assessed with it good potentiality and the KFDA required high standards of clinical studies for the health registration of new drugs. Moreover, the new environment requiring IND system from Fe...